Universe Pharmaceuticals INC Quarterly Liabilities and Equity in USD from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Universe Pharmaceuticals INC quarterly Liabilities and Equity history and growth rate from Q3 2020 to Q1 2024.
  • Universe Pharmaceuticals INC Liabilities and Equity for the quarter ending March 31, 2024 was $49.4M, a 29.8% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $49.4M -$20.9M -29.8% Mar 31, 2024 6-K 2024-09-20
Q3 2023 $53.3M -$6.25M -10.5% Sep 30, 2023 6-K 2024-09-20
Q1 2023 $70.4M -$998K -1.4% Mar 31, 2023 6-K 2023-08-31
Q3 2022 $59.5M -$10.6M -15.1% Sep 30, 2022 20-F 2024-01-30
Q1 2022 $71.4M Mar 31, 2022 6-K 2022-08-16
Q3 2021 $70.1M +$41.3M +144% Sep 30, 2021 20-F 2023-02-10
Q3 2020 $28.8M Sep 30, 2020 20-F 2022-01-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.